| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
In the preceding three months, 8 analysts have released ratings for American Healthcare REIT (NYSE:AHR), presenting a wide array of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 5 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 1 | 1 | 0 | 0 | 0 |
| 2M Ago | 1 | 2 | 0 | 0 | 0 |
| 3M Ago | 0 | 2 | 0 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $45.12, a high estimate of $51.00, and a low estimate of $41.00. This upward trend is apparent, with the current average reflecting a 11.13% increase from the previous average price target of $40.60.
In examining recent analyst actions, we gain insights into how financial experts perceive American Healthcare REIT. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Michael Goldsmith | UBS | Announces | Buy | $51.00 | - |
| Nicholas Yulico | Scotiabank | Raises | Sector Outperform | $47.00 | $42.00 |
| Michael Lewis | Truist Securities | Raises | Buy | $46.00 | $44.00 |
| Michael Lewis | Truist Securities | Raises | Buy | $44.00 | $38.00 |
| Michael Carroll | RBC Capital | Raises | Outperform | $45.00 | $39.00 |
| Aaron Hecht | JMP Securities | Raises | Market Outperform | $45.00 | $40.00 |
| Wesley Golladay | Baird | Announces | Outperform | $41.00 | - |
| Nicholas Yulico | Scotiabank | Announces | Sector Outperform | $42.00 | - |
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into American Healthcare REIT's market standing. Stay informed and make well-considered decisions with our Ratings Table.
Stay up to date on American Healthcare REIT analyst ratings.
American Healthcare REIT Inc is a healthcare-focused real estate investment trust. It owns a diversified portfolio of clinical healthcare real estate properties, focusing on medical office buildings, skilled nursing facilities, senior housing, hospitals, and other healthcare-related facilities. It has four reportable business segments: integrated senior health campuses, outpatient medical, triple-net leased properties and SHOP. It generates majority of its revenue through Integrated Senior Health Campuses segment.
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: American Healthcare REIT's remarkable performance in 3M is evident. As of 30 June, 2025, the company achieved an impressive revenue growth rate of 7.52%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Real Estate sector.
Net Margin: American Healthcare REIT's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 1.83%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 0.42%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.22%, the company showcases effective utilization of assets.
Debt Management: American Healthcare REIT's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.71.
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: AHR
